Lack of association between prohibitin 3′ untranslated region C→T polymorphism and breast cancer in a Turkish population

DNA and Cell Biology

Volumn 27, Issue 8, 2008, Pages 449-452

  Karakus, Nevin ^a   Kara, Nurten ^a   Ulusoy, Ali Naki ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

PROHIBITIN; CYTOSINE; REPRESSOR PROTEIN; TYROSINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC); UNTRANSLATED REGION; BREAST TUMOR; DNA FLANKING REGION; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; STANDARD;

3' FLANKING REGION; BREAST NEOPLASMS; CYTOSINE; FEMALE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE STANDARDS; REPRESSOR PROTEINS; TURKEY; TYROSINE;

EID: 51649093861     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2007.0724     Document Type: Article

References (21)

1. Campbell, I.G., Allen, J., and Eccles, D.M. (2003). Prohibitin 3′untranslated region polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12, 1273-1274.
2. Davis, S., and Watson, J.C. (1996). In vitro activation of the interferon-induced, double stranded RNA dependent protein kinase PKR by RNA from the 3′untranslated regions of human α-tropomyosin. Proc Natl Acad Sci USA 93, 508-513.
3. Grimm, C., Polterauer, S., Zeillinger, R., Tempfer, C., Sliutz, G., Reinthaller, A., and Hefler, L.A. (2008). The prohibitin 3′untranslated region polymorphism in patients with ovarian cancer. Eur J Obstet Gynecol 137, 236-239.
4. He, Y.Z., and Liu, D.G. (2000). Three-hybrid strategy reveals a peptide segment that specifically binds to 3′-untranslated region of NF-IL6 mRNA. Biochem Biophys Res Commun 276, 101-106.
5. Ikonen, E., Fiedler, K., Patron, R.G., and Simons, K. (1995). Prohibitin, an antiproliferative protein, is located to mitochondria. FEBS Lett 358, 273-277.
6. Jakubowska, A., Gronwald, J., Gorski, B., Huzarski, T., Byrski, T., Benner, A., Lubiński, J., Scott, R.J., and Hamann, U. (2007). The 3′untranslated region C>T polymorphism of prohibitin is a breast cancer risk modifier in Polish women carrying a BRCA1 mutation. Breast Cancer Res Treat 104, 67-74.
7. Jupe, E.R., Liu, X.T., Kiehlbauch, J.L., McClung, J.K., and Dell'Orco, R.T. (1996). Prohibitin in breast cancer cell lines: loss of antiproliferative activity is linked to 3′untranslated region mutations. Cell Growth Differ 7, 871-878.
8. Jupe, E.R., Badgett, A.A., Neas, B.R., Craft, M.A., Mitchell, D.S., Resta, R., Mulvihill, J.J., Aston, C.E., and Thompson, L.F. (2001). Single nucleotide polymorphism in prohibitin 3′untranslated region and breast-cancer susceptibility. Lancet 357, 1588-1589.
9. Liu, D.G., Jiang, Q.H., Wei, Y.Y., Sun, L., Fu, B.B., Zhao, F.K., and Zhou, Q. (2003). Gene expression profile favoring phenotypic reversion: a clue for mechanism of tumor suppression by NF-IL6 3′UTR. Cell Res 13, 509-514.
10. López de Silanes, I., Quesada, M.P., and Etseller, M. (2007). Aberrant regulation of messenger RNA 3′-untranslated region in human cancer. Cell Oncol 29, 1-17.
11. Manjeshwar, S., Branam, D.E., Lerner, M.R., Brackett, D.J., and Jupe, E.R. (2003). Tumor suppression by the prohibitin gene 3′untranslated region RNA in human breast cancer. Cancer Res 63, 5251-5256.
12. Manjeshwar, S., Lerner, M.R., Zang, X.-P., Branam, D.E., Pento, J.T., Lane, M.M., Lightfoot, S.A., Brackett, D.J., and Jupe, E.R. (2004). Expression of prohibitin 3′ untranslated region suppressor RNA alters morphology and inhibits motility of breast cancer cells. J Mol Histol 35, 639-646.
13. McClung, J.K., King, R.L., Walker, L.S., Danner, D.B., Nuell, M.J., Stewart, C.A., and Dell'Orco, R.T. (1992). Expression of prohibitin, an antiproliferative protein. Exp Gerontol 27, 413-417.
14. McClung, J.K., Jupe, E.R., Liu, X.-T., and Dell'Orco, R.T. (1995). Prohibitin: potential role in senescence, development and tumor suppression. Exp Gerontol 30, 99-124.
15. Nagai, M.A., Yamamoto, L., Salaomi, S., Pacheco, M.M., Bretani, M.M., Barbosa, E.M., Brentani, R.R., Mazoyer, S., Smith, S.A., Ponder, B.A.J., and Mulligan, L.M. (1994). Detailed deletion mapping of chromosome segment 17q12-21 in sporadic breast tumors. Genes Chromosomes Cancer 11, 58-62.
16. Rastinejad, F., and Blau, H.M. (1993). Genetic complementation reveals a novel regulatory for 3′untranslated region in growth and differentiation. Cell 72, 903-917.
17. Snedden, W.A., and Fromm, H. (1997). Characterization of the plant homologue of prohibitin, a gene associated with antiproliferative activity in mammalian cells. Plant Mol Biol 33, 753-756.
18. Spurdle, A.B., Hopper, J.L., Chen, X., McCredie, M.R., Giles, G.G., Newman, B., and Chenevix-Trench, G. (2002). Prohibitin 3′untranslated region polymorphism and breast cancer risk in Australian women. Lancet 360, 925-926.
19. Spurdle, A.B., Purdie, D.M., Chen, X., and Chenevix-Trench, G. (2003). The prohibitin 3′untranslated region polymorphism is not associated with risk of ovarian cancer. Gynecol Oncol 90, 145-149.
20. Wang, S., Nath, N., Adlam, M., and Chellappan, S. (1999). Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 18, 3501-3510.
21. White, J.J., Ledbetter, D.H., Eddy, R.L., Shows, T.B., Stewart, D.A., Nuell, M.J., Friedman, V., Wood, C.M., Owens, G.A., McClung, J., Danner, D.B., and Morton, C.C. (1991). Assignment of the prohibitin gene (PHB) to chromosome 17 and identification of DNA polymorphism. Genomics 11, 228-230.